Dr. Kittai Discusses Richter Transformation in CLL: Unmet Needs, Novel Therapies
Автор: Blood Cancers Today
Загружено: 2024-09-16
Просмотров: 348
Adam Kittai, MD, of the Icahn School of Medicine at Mount Sinai, joins Blood Cancers Today at the Society of Hematologic Oncology 2024 Annual Meeting in Houston, Texas, to discuss Richter transformation in chronic lymphocytic leukemia (CLL).
Dr. Kittai described three trials evaluating novel therapies for Richter transformation:
• Pirtobrutinib
• Zanabrutinib plus tislelizumab
• Chimeric antigen receptor T-cell therapy
“There's encouraging data out there using our new medications for Richter transformation, but we still have a lot of work to do to figure out how best to treat these patients,” Dr. Kittai said.
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: